| Product Code: ETC7745529 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Pharmacogenetic Testing Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Japan Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Japan Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Japan Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Japan Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Japan Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Japan Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Japan Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Japan Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Rising prevalence of chronic diseases in Japan |
4.2.3 Technological advancements in the field of pharmacogenetic testing |
4.3 Market Restraints |
4.3.1 High costs associated with pharmacogenetic testing |
4.3.2 Limited awareness among healthcare professionals and patients |
4.3.3 Regulatory challenges and lack of standardized guidelines for pharmacogenetic testing |
5 Japan Pharmacogenetic Testing Market Trends |
6 Japan Pharmacogenetic Testing Market, By Types |
6.1 Japan Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Japan Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Japan Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Japan Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Japan Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Japan Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Japan Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Japan Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Japan Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Japan Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Japan Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Japan Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Japan Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Japan Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Japan Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Japan Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Japan Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Japan Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Japan Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Japan Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Japan Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Japan Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Japan Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Japan Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Japan Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Japan Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Japan Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Japan Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Japan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Japan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Japan Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Japan Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Japan Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Japan Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Japan Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Japan Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Japan Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Japan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Japan Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Japan Pharmacogenetic Testing Market Export to Major Countries |
7.2 Japan Pharmacogenetic Testing Market Imports from Major Countries |
8 Japan Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetic testing by healthcare providers |
8.2 Number of clinical trials incorporating pharmacogenetic testing |
8.3 Percentage of healthcare institutions offering pharmacogenetic testing |
8.4 Rate of insurance coverage for pharmacogenetic testing |
8.5 Patient satisfaction and outcomes following pharmacogenetic testing |
9 Japan Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Japan Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Japan Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Japan Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Japan Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Japan Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Japan Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Japan Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Japan Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Japan Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here